卵巢癌循环肿瘤细胞的生物学特性及其临床应用进展

孙昱; 符达; 刘兴党; 孙昱; 符达; 刘兴党

doi:10.3760/cma.j.issn.1673-4114.2016.01.012

[1]

张旭, 史小荣.联合检测肿瘤标志物在卵巢癌诊断中的应用进展[J].中国当代医药, 2013, 20(10):23-24, 31.DOI:10.3969/j.issn.1674-4721.2013.10.009.
Zhang X, Shi XR.Application of combined measurement of tumor markers in the diagnosis of ovarian cancer[J].Chin Mod Med, 2013, 20(10):23-24, 31. doi: 10.3969/j.issn.1674-4721.2013.10.009

[2]

Ashworth T.A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J].Aust Med J, 1986, 14:146-149.

[3]

刘志勇, 李宝江.乳腺癌新辅助化疗中循环肿瘤细胞的动态变化及疗效观察[J].中国肿瘤临床, 2013, 40(23):1431-1435.DOI:10.3969/j.issn.1000-8179.20131252.
Liu ZY, Li BJ.Efficacy of neoadjuvant chemotherapy on breast cancer and dynamic changes of circulating tumor cells[J].Chin J Clin Oncol, 2013, 40(23):1431-1435. doi: 10.3969/j.issn.1000-8179.20131252

[4]

Alva A, Friedlander T, Clark M, et al.Circulating tumor cells as potential biomarkers in bladder cancer[J].J Urol, 2015, 194(3):790-798.DOI:10.1016/j.juro.2015.02.2951.

[5]

Kolostova K, Broul M, Schraml J, et al.Circulating tumor cells in localized prostate cancer:isolation, cultivation in vitro and relationship to T-stage and Gleason score[J].Anticancer Res, 2014, 34(7):3641-3646.

[6]

Poveda A, Kaye SB, Mccormack R, et al.Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J].Gynecol Oncol, 2011, 122(3):567-572.DOI:10.1016/j.ygyno.2011.05.028.

[7]

Ning N, Zhan T, Zhang Y, et al.Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization[J].Clin Chim Acta, 2014, 433:69-75.DOI:10.1016/j.cca.2014.02.019.

[8]

Pearl ML, Zhao Q, Yang J, et al.Prognostic analysis of invasive circulating tumor cells(iCTCs)in epithelial ovarian cancer[J].Gynecol Oncol, 2014, 134(3):581-590.DOI:10.1016/j.ygyno.2014.06.013.

[9]

李世超, 姜军.乳腺癌循环肿瘤细胞生物学特性的研究进展[J].中华肿瘤防治杂志, 2012, 19(16):1272-1275.DOI:10.16073/j.cnki.cjcpt.2012.16.004.
Li SC, Jiang J.Progress in biological characteristics of circulating breast-tumor cells[J].Chin J Cancer Prev Treat, 2012, 19(16):1272-1275. doi: 10.16073/j.cnki.cjcpt.2012.16.004

[10]

Vona G, Sabile A, Louha M, et al.Isolation by size of epithelial tumor cells:a new method for the immunomorphological and molecular characterization of circulatingtumor cells[J].Am J Pathol, 2000, 156(1):57-63.DOI:10.1016/S0002-9440(10)64706-2.

[11]

Choi H, Kim KB, Jeon CS, et al.A label-free DC impedance-based microcytometer for circulating rare cancer cell counting[J].Lab Chip, 2013, 13(5):970-977.DOI:10.1039/c2lc41376k.

[12]

刘慧颖, 殷正丰.上皮间质转化与循环肿瘤细胞[J].肿瘤, 2013, 33(9):837-840.DOI:10.3781/j.issn.1000-7431.2013.09.015.
Liu HY, Yin ZF.Epithelial-mesenchymal transition and circulating tumor cells[J].Tumor, 2013, 33(9):837-840. doi: 10.3781/j.issn.1000-7431.2013.09.015

[13]

曾晶, 陈东妮, 徐进.角蛋白与肿瘤[J].中国细胞生物学学报, 2012, 34(5):485-492.
Zeng J, Chen DN, Xu J.Keratins and Tumors[J].Chin J Cell Biol, 2012, 34(5):485-492.

[14]

孙凯旋, 陈曦, 陈说, 等.CK7和CA125在人卵巢癌的表达及意义[J].解剖科学进展, 2014, 20(3):237-239, 245.
Sun KX, Chen X, Chen S, et al.The expression and significance of CK7 and CA125 in human ovarian cancer[J].Prog Anat Sci, 2014, 20(3):237-239, 245.

[15]

孙红敏, 苑中甫.原发及转移性卵巢癌组织中绒毛蛋白、细胞角蛋白7及20的表达[J].郑州大学学报:医学版, 2007, 42(2):345-347.DOI:10.3969/j.issn.1671-6825.2007.02.053.
Sun HM, Yuan ZF.Expression of villin, CK7, and CK20 in primary and metastatic ovarian carcinoma tissue[J].J Zhengzhou Univ(Med Sci), 2007, 42(2):345-347. doi: 10.3969/j.issn.1671-6825.2007.02.053

[16]

Judson PL, Geller MA, Bliss RL, et al.Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer[J].Gynecol Oncol, 2003, 91(2):389-394.DOI:10.1016/j.ygyno.2003.08.004.

[17]

Ntouroupi TG, Ashraf SQ, Mcgregor SB, et al.Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope[J].Br J Cancer, 2008, 99(5):789-795.DOI:10.1038/sj.bjc.6604545.

[18]

Aktas B, Kasimir-Bauer S, Heubner M, et al.Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy[J].Int J Gynecol Cancer, 2011, 21(5):822-830.DOI:10.1097/IGC.0b013e318216cb91.

[19]

蒋胜, 李力, 张玮, 等.ERCC1基因mRNA表达水平在卵巢上皮性癌组织中的意义[J].实用妇产科杂志, 2009, 25(11):661-663.DOI:10.3969/j.issn.1003-6946.2009.11.011.
Jiang S, Li L, Zhang W, et al.ERCC1 mRNA expression level as a prognostic factor for epithelial ovarian cancer[J].J Pract Obstet Gynecol, 2009, 25(11):661-663. doi: 10.3969/j.issn.1003-6946.2009.11.011

[20]

Kuhlmann JD, Wimberger P, Bankfalvi A, et al.ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for Platinum resistance[J].Clin Chem, 2014, 60(10):1282-1289.DOI:10.1373/clinchem.2014.224808.

[21]

Obermayr E, Castillo-Tong DC, Pils D, et al.Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance——a study of the OVCAD consortium[J].Gynecol Oncol, 2013, 128(1):15-21.DOI:10.1016/j.ygyno.2012.09.021.

[22]

He W, Kularatne SA, Kalli KR, et al.Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands[J].Int J Cancer, 2008, 123(8):1968-1973.DOI:10.1002/ijc.23717.

[23]

Feng H, Ghazizadeh M, Konishi H, et al.Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas[J].Jpn J Clin Oncol, 2002, 32(12):525-529.DOI:10.1093/jjco/hyf111.

[24]

曾新红.卵巢癌组织中GST-π和muc1基因的表达及临床意义[D].北京: 中国人民解放军军医进修学院, 2004.

Zeng XH.GST-π and muc1 gene expression in ovarian carcinoma tissue and their clinical significance[D].Beijing: Chin PLA Postgraduate Med School, 2004.

[25]

Wang L, Ma J, Liu F, et al.Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance[J].Gynecol Oncol, 2007, 105(3):695-702.DOI:10.1016/j.ygyno.2007.02.004.

[26]

陆松梅, 周琦, 张娜, 等.EPCAM、MUC16免疫磁珠制备及循环肿瘤细胞检测[J].免疫学杂志, 2015, 31(6):517-522 DOI:10.13431/j.cnki.immunol.j.20150110.
Lu SM, Zhou Q, Zhang N, et al.EPCAM and MUC16 immunomagnetic beads preparation and circulating tumor cells detection[J].J Immunol, 2015, 31(6):517-522. doi: 10.13431/j.cnki.immunol.j.20150110

[27]

He S, Li P, Chen X, et al.Fluid biopsy for circulating tumor cells in an occult ovarian cancer patient exhibiting bilateral supraclavicular lymph node metastases:A case report[J].Oncol Lett, 2013, 6(2):448-452.DOI:10.3892/ol.2013.1364.

[28]

Fan T, Zhao Q, Chen JJ, et al.Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer[J].Gynecol Oncol, 2009, 112(1):185-191.DOI:10.1016/j.ygyno.2008.09.021.

[29]

Liu JF, Kindelberger D, Doyle C, et al.Predictive value of circulating tumor cells(CTCs)in newly-diagnosed and recurrent ovarian cancer patients[J].Gynecol Oncol, 2013, 131(2):352-356.DOI:10.1016/j.ygyno.2013.08.006.

[30]

Marth C, Kisic J, Kaern J, et al.Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis[J].Cancer, 2002, 94(3):707-712.DOI:10.1002/cncr.10250.